Developing drugs that target the Wnt pathway: recent approaches in cancer and neurodegenerative diseases
2017
ABSTRACTIntroduction: Wnt/β-catenin signaling is an evolutionarily conserved pathway that has a crucial role in embryonic and adult life. Dysregulation of Wnt/β-catenin pathway has been associated with various diseases, including cancer and neurodegenerative disorders, including Parkinson’s disease (PD). Several molecular components of the signaling have been proposed as innovative targets for cancer therapy, and very recently, some of them have been also evaluated as potential therapeutic targets for PD.Areas covered: This review focuses on the role of Wnt/β-catenin pathway in the pathogenensis of cancer and PD, examining some recent therapeutic approaches that are ongoing in preclinical and clinical studies. The possibilities that this signaling offers for diagnosis and prognosis of neoplastic diseases, and the concerns of targeting this pathway are also discussed.Expert opinion: Despite the stimulating results obtained in preclinical studies on cancer and other disease models, the clinical experience w...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
133
References
34
Citations
NaN
KQI